8-K: Berto SPAC Eyes OnMed for Healthcare Infrastructure Merger

Berto Acquisition Corp. and OnMed LLC have signed a non-binding letter of intent for a potential business combination, aiming to address America's healthcare access crisis.

Summary

• Berto Acquisition Corp., a special purpose acquisition company (SPAC), and OnMed LLC, a developer of healthcare infrastructure solutions, have entered into a non-binding Letter of Intent (LOI) for a potential business combination.
• OnMed has developed the 'CareStationTM,' an 8x10 foot 'Clinic-in-a-Box' solution designed to provide personalized, patient-first healthcare with live clinicians, real-time diagnostic tools, and e-prescriptions.
• The initiative aims to address America's critical healthcare access crisis, noting that 80% of U.S. counties qualify as healthcare deserts and over 120 million Americans lack adequate access to healthcare.
• OnMed's CareStations are significantly more cost-effective to deploy than traditional in-office clinics, which can cost upwards of $2.5 million to build and run, and do not require in-office staff.
• OnMed reports that 85% of patients are fully diagnosed without a specialist referral, and 50% of patients stated they would have otherwise sought care at an emergency room or urgent care facility.
• Patient satisfaction with CareStations is high, with a 4.96 out of 5 satisfaction score and 99% willingness to return or recommend the service.
• CareStations can be fully operational within 30 days from contract signing to deployment.
• OnMed currently has CareStations contracted across seven states and Puerto Rico, with plans for significant expansion in 2026.
• Karthik Ganesh, the current CEO of OnMed, is expected to lead the combined company following the business combination.

Sentiment

Score: 7

Explanation: The announcement of a non-binding LOI for a business combination is generally positive for both companies, especially for OnMed gaining public market access. OnMed's described solution addresses a critical market need with strong reported performance metrics. However, the non-binding nature and numerous conditions introduce significant uncertainty, preventing a higher score.

Positives

• The proposed business combination addresses a significant societal challenge by providing scalable healthcare access in underserved areas.
• OnMed's CareStation offers a cost-effective and efficient alternative to traditional clinics and addresses the limitations of basic telemedicine.
• High patient satisfaction (4.96/5) and strong willingness to return or recommend (99%) indicate a successful service model.
• Rapid deployment capability of CareStations (30 days from contract to operational) allows for quick expansion and impact.
• OnMed exhibits strong growth, an emerging free cash flow positive model, and an IP-protected platform, as highlighted by Berto's Chairman.
• OnMed has received multiple industry recognitions, including TIME's 2025 List of Best Inventions and a 2025 Great Place to Work award.
• Karthik Ganesh, OnMed's experienced CEO, is slated to lead the combined company, ensuring continuity and strategic direction.

Negatives

• The agreement is a non-binding Letter of Intent, meaning there is no guarantee that a definitive agreement will be successfully negotiated or that the transaction will be consummated.
• The proposed business combination is subject to numerous conditions, including due diligence, negotiation of a definitive agreement, board and equity holder approvals, and regulatory clearances.
• No specific financial terms, valuation, or equity split details of the proposed transaction were disclosed in the filing.

Risks

• The negotiations for a definitive business combination agreement may terminate, or a definitive agreement may not be entered into at all.
• The proposed transaction may not be consummated on the terms or timeframe currently contemplated, or may not occur.
• The terms and conditions set forth in any definitive agreement may differ materially from those outlined in the non-binding letter of intent.
• Legal proceedings may be instituted against the parties following the announcement of the proposed business combination.
• The inability to complete the proposed transaction due to failure to obtain shareholder approval from Berto or OnMed, or other closing conditions not being met.
• The inability to obtain or maintain the listing of the post-acquisition company's common stock on Nasdaq, the New York Stock Exchange, or another national securities exchange.
• The proposed transaction could disrupt current plans and operations of both Berto and OnMed.
• The combined company may not be able to recognize the anticipated benefits of the proposed transaction, potentially affected by competition, challenges in managing growth, or retaining key employees.
• Significant costs related to the proposed transaction could impact financial performance.
• Changes in applicable laws or regulations could adversely affect the combined company's operations or financial results.

Future Outlook

The companies anticipate negotiating and entering into a definitive agreement for a business combination, which would result in the combined entity being publicly listed. OnMed plans to significantly expand its CareStation footprint in 2026, continuing to address the healthcare access crisis across the U.S. and Puerto Rico.

Management Comments

• "We are excited to partner with the Berto team because of their significant experience and success in scaling tech-enabled infrastructure solutions." Karthik Ganesh, CEO of OnMed.
• "OnMed's purpose is to improve the quality of life and sense of wellbeing in the communities where CareStations are deployed." Karthik Ganesh, CEO of OnMed.
• "We are proving that this model works." Karthik Ganesh, CEO of OnMed.
• "We could not be more pleased and excited to work with Karthik and his team at OnMed, who have created a scalable solution that combines the best of technology and innovative infrastructure solutions." Harry You, Chairman of Berto Acquisition Corp.
• "OnMed has the financial and business characteristics we like to see for the companies we have taken public – strong growth, an emerging free cash flow positive model, an IP-protected platform, and a massive addressable market with the potential to be extended further by cutting edge technologies like AI." Harry You, Chairman of Berto Acquisition Corp.

Industry Context

This proposed business combination highlights the ongoing trend of innovative solutions addressing the U.S. healthcare access crisis, particularly in 'healthcare deserts.' OnMed's CareStation model positions itself as a hybrid solution, bridging the gap between traditional in-person clinics and pure telemedicine by offering comprehensive care with real-time diagnostics in a scalable, cost-effective 'Clinic-in-a-Box' format. The transaction also reflects the continued activity in the SPAC market for bringing growth-oriented, tech-enabled companies public.

Comparison to Industry Standards

• OnMed CareStations can be deployed for a fraction of the cost of traditional in-office clinics, which can cost upwards of $2.5 million to build and run, without the need for in-office staff.
• CareStations address the clinical shortcomings of traditional telemedicine by providing one-on-one clinical consultation with a live clinician, real-time diagnostic tools, and e-prescriptions, enabling comprehensive patient examinations that traditional telehealth often cannot support.
• The OnMed experience provides the psychological comfort and comprehensiveness of a traditional clinic visit, combined with the rapid scalability of virtual care, offering a unique blend compared to existing healthcare delivery models.

Management Changes

Corporate Governance

Legal Proceedings

• There is a risk that legal proceedings may be instituted against the parties following the announcement of the proposed business combination and any subsequent definitive agreements.

Stakeholder Impact

• Shareholders of Berto Acquisition Corp. face potential for significant value creation or dilution, contingent on the definitive terms of the merger and the future performance of the combined entity.
• Employees of OnMed LLC may experience increased opportunities and benefits associated with being part of a publicly traded company, with continuity in leadership under CEO Karthik Ganesh.
• Patients and communities, particularly those in healthcare deserts, stand to benefit from expanded access to convenient, comprehensive, and cost-effective healthcare services through OnMed's CareStations.
• OnMed's partners, including payors, providers, government agencies, employers, and educational institutions, may see strengthened collaborations due to increased capital and the enhanced public profile of the combined company.

Next Steps

• Negotiate and enter into a definitive business combination agreement.
• Complete due diligence by both parties.
• Obtain board and equity holder approvals for the proposed transaction from both Berto and OnMed.
• Secure necessary regulatory approvals for the business combination.
• Berto or a newly formed holding company will prepare and file a registration statement, including a proxy statement/prospectus, with the U.S. Securities and Exchange Commission (SEC).
• OnMed plans to significantly expand its CareStation footprint in 2026.

Key Dates

Recommendation

The announcement is a non-binding Letter of Intent, indicating a potential future transaction rather than a finalized deal. While OnMed presents an attractive business model addressing a critical market need with strong reported performance metrics, significant uncertainties remain regarding the definitive terms, valuation, and successful completion of the business combination. Investors should hold existing positions and await further details, including the definitive agreement and proxy statement/prospectus, to make a more informed decision.

Keywords

SPAC, Healthcare Infrastructure, OnMed, Berto Acquisition Corp, Business Combination, Telemedicine, Healthcare Access, CareStation, Medical Technology, Merger